Are the new moisturizers more effective?

Current Opinion in Pediatrics

Volumn 21, Issue 4, 2009, Pages 486-490

  Anderson, P Chris ^a,b   Dinulos, James G ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Atopic dermatitis; Ceramide; Emollients; Humectants; Moisturizers; Pseudo ceramide

Indexed keywords

AQUAFOR; ATOPICLAIR; CERAMIDE; CERAVE; CETAPHIL; CUREL; EMOLLIENT AGENT; HUMECTANT; LANOLIN ALCOHOL; METHYLPREDNISOLONE ACEPONATE; MIMYX; MOISTUREL; NIVEA; REMERGENT; TACROLIMUS; TRICERAM; TRUE MOISTURE; UNCLASSIFIED DRUG; VANICREAM;

ATOPIC DERMATITIS; CREAM; HUMAN; LOTION; MOISTURE; OINTMENT; PRIORITY JOURNAL; REVIEW; SKIN CARE; STEROID THERAPY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; CERAMIDES; DERMATITIS, ATOPIC; EMOLLIENTS; HUMANS; PERMEABILITY; SKIN; SKIN ABSORPTION; SKIN CARE; TREATMENT OUTCOME; WATER LOSS, INSENSIBLE;

EID: 68949204192     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32832cfd3b     Document Type: Review

References (18)

1. Lodén M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005; 19:672-688; quiz 686-687.
2. Kraft JN, Lynde CW. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Lett 2005; 10:1-8.
3. Lynde CW. Moisturizers: what they are and how they work. Skin Therapy Lett 2001; 6:3-5.
4. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 2005; 6:215-223.
5. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17:1063-1072.
6. Endo K, Suzuki N, Yoshida O, et al. The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Skin Res Technol 2007; 13:425-435.
7. Tagami H, Kobayashi H, O'goshi K, et al. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products. J Cosmet Dermatol 2006; 5:140-149.
8. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47:198-208.
9. Sawai H, Domae N, Okazaki T. Current status and perspectives in ceramide-targeting molecular medicine. Curr Pharm Des 2005; 11:2479-2487.
10. Uchida Y, Holleran WM, Elias PM. On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides. J Dermatol Sci 2008; 51:37-43.
11. Matsumoto T, Yuasa H, Kai R, et al. Skin capacitance in normal and atopic infants, and effects of moisturizers on atopic skin. J Dermatol 2007; 34:447-450.
12. Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immuno 2008; 19:614-618.
13. Paslin D, Wertz P. A study to determine the effect of tacrolimus on ceramide levels in the stratum corneum of patients with atopic dermatitis. Int J Dermatol 2006; 45:352-356.
14. Kang JS, Yoon WK, Youm JK, et al. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice. Exp Dermatol 2008; 17:958-964.
15. Is True MoistureTM equal to PerfectionTM, CeraVeTM Cream, EpiceramTM, and TriceramTM? What's the difference? [Online]. http://www.truemoisture.com/ question30.asp. [Accessed February 2009]
16. Patented Multivesicular Emulsion (MVE) delivery technology 2008; 17:958-964. http://www.cerave.com/mve.htm. [Accessed February 2009]
17. Berson D. Recommendation of moisturizers and cleansers: a study of unmet needs among dermatology patients. Cutis 2005; 76 (6 Suppl):3-6.
18. Higham R. Integration of moisturizers and cleansers into a busy dermatology practice. Cutis 2005; 76 (6 Suppl):32-33.